Chronic kidney disease
Conditions
Interventions
cohort group:basic treatment
treatment group:basic treatment
cohort group:Original Chinese patent medicine treatment
treatment group:Chinese patent medicine treatment based on syndrome differentiation
Sponsors
BEIJING HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? Patients with ckD3-4 stage diagnosis; ? Aged between 18 and 75; ? Did not receive renal replacement therapy; ? Those who voluntarily accept treatment and sign informed consent.
Exclusion criteria
Exclusion criteria: ? Recent (within 4 weeks) severe infection, severe anemia, electrolyte disorder and other complications; ? Patients with severe diseases of heart, brain, liver and hematopoietic system (cerebral infarction, cerebral hemorrhage, transient ischemic attack, myocardial infarction, unstable angina pectoris, heart failure, and elevation of aminotransferase to more than 2 times of the upper limit of normal range) had occurred in 3 months before enrollment; ? with acute kidney injury; Oliguria or no urine, severe edema, large pleural effusion, abdominal effusion; ? Patients with kidney disease secondary to various tumors; ? With wasting diseases such as tuberculosis or a history of mental diseases; ? women who are pregnant or preparing for pregnancy or lactation; Within 12 weeks, he used glucocorticoid, immunosuppressant and Tripterygium wilfordii preparation. (8) patients known to be allergic to the drugs used; ? Those who are participating in other interventional clinical trials or have participated in other clinical trials within 12 weeks;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| estimated glomerular filtration rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood calcium;total plasma protein;Serum creatinine;Serum kalium;routine urine test;uric acid;Quality of life evaluation;The average cost;Traditional Chinese Medicine Symptom Score;blood urea nitrogen;albumin;Hemoglobin;admission time;Serum phosphate; | — |
Countries
CHINA
Contacts
Public ContactZhao Wenjing
Outcome results
None listed